July 28, 2016
Mayo Clinic Studying Genomics of Antiplatelet Heart Medication
By Sharon Rosen
Angioplasty offers lifesaving treatment without open heart surgery. But, it comes with risks. Researchers at the Center for Individualized Medicine are trying to determine if your individual genetic blue print can pinpoint drugs that reduce the risk of dangerous side effects. The Tailored Antiplatelet Therapy to Lessen Outcomes After Percutaneous Coronary Intervention (TAILOR-PCI) Study examines […]
Tags: #Antiplatlet Heart Medication, #Ticagrelor, angioplasty, Biomedical research, clopidogrel, Dr. Chet Rihal, Dr. Naveen Pereira, medical research, pharmacogenomics